CIPLA's weekly return of -4.69% was the worst among its peers, with a relatively low volatility of 11.37%. The stock's Sharpe Ratio of -2.21 indicates a poor risk-adjusted performance. Compared to its peers, CIPLA underperformed SUNPHARMA and GRASIM, but outperformed DIVISLAB. Overall, the stock's risk profile was moderate this week.

[Volatility: 11.37%]